ChristianaCare Helen F Graham Cancer Center and Research Institute — Newark, Delaware

ChristianaCare Helen F Graham Cancer Center and Research Institute is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

ChristianaCare Helen F Graham Cancer Center and Research Institute has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Multiple Myeloma.

Sponsors: Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ChristianaCare Helen F Graham Cancer Center and Research Institute?

ChristianaCare Helen F Graham Cancer Center and Research Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ChristianaCare Helen F Graham Cancer Center and Research Institute conducted?

ChristianaCare Helen F Graham Cancer Center and Research Institute has 2 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Multiple Myeloma.

Is ChristianaCare Helen F Graham Cancer Center and Research Institute accredited by Crixeo Health?

ChristianaCare Helen F Graham Cancer Center and Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ChristianaCare Helen F Graham Cancer Center and Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.